Handok & Teva-Handok sign joint sales agreement of respiratory disease treatments in Korea

Handok Inc.(Chairman Young-Jin Kim) and Teva-Handok(CEO Sung-Dong Park) held an agreement ceremony for joint sales of Teva-Handok’s respiratory disease treatments at the Handok headquarters on 26 October.

Under the agreement, the two companies will jointly sell Teva-Handok’s respiratory disease treatments, such as ‘Duoresp Spiromax,’ a asthma and COPD treatment, and ‘Cinqair Inj,’ a severe eos...